TRiCares gains FDA IDE to initiate tricuspid regurgitation treatment pivotal trial
TRiCares has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA) to initiate a…
TRiCares has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA) to initiate a…